Format

Send to

Choose Destination
Clin Exp Ophthalmol. 2016 May;44(4):260-77. doi: 10.1111/ceo.12696. Epub 2016 Feb 17.

Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review.

Ting DS1,2, Cheung GC1,2,3, Wong TY4,5,6.

Author information

1
Singapore National Eye Center, Singapore Health Service (SingHealth), Singapore, Singapore.
2
Singapore Eye Research Institute, Singapore, Singapore.
3
Duke-NUS Graduate Medical School, Singapore, Singapore.
4
Singapore National Eye Center, Singapore Health Service (SingHealth), Singapore, Singapore. tien_yin_wong@nuhs.edu.sg.
5
Singapore Eye Research Institute, Singapore, Singapore. tien_yin_wong@nuhs.edu.sg.
6
Duke-NUS Graduate Medical School, Singapore, Singapore. tien_yin_wong@nuhs.edu.sg.

Abstract

Diabetes retinopathy (DR) is a leading cause of vision loss in middle-aged and elderly people globally. Early detection and prompt treatment allow prevention of diabetes-related visual impairment. Patients with diabetes require regular follow-up with primary care physicians to optimize their glycaemic, blood pressure and lipid control to prevent development and progression of DR and other diabetes-related complications. Other risk factors of DR include higher body mass index, puberty and pregnancy, and cataract surgery. There are weaker associations with some genetic and inflammatory markers. With the rising incidence and prevalence of diabetes and DR, public health systems in both developing and developed countries will be faced with increasing costs of implementation and maintenance of a DR screening program for people with diabetes. To reduce the impact of DR-related visual loss, it is important that all stakeholders continue to look for innovative ways of managing and preventing diabetes, and optimize cost-effective screening programs within the community.

PMID:
26716602
DOI:
10.1111/ceo.12696
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center